QQ客服 官方微博 反馈留言

	The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I
	Fu Xiu-Qiong[1]; Chou Ji-Yao[2]; Li Ting[3]; Zhu Pei-Li[4]; Li Jun-Kui[5]; Yin Cheng-Le[6]; Su Tao[7]; Guo Hui[8]; Lee Kin-Wah[9]; Hossen Muhammad Jahangir[10]
刊名	Experimental dermatology
	2018
卷号	27页码:201-204
关键词	Cytotoxicity apoptosis metastasis molecular pathways targeted therapy
ISSN号	1600-0625
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2181831
专题	上海大学
作者单位	1.Center for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. 2.Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
推荐引用方式 GB/T 7714	Fu Xiu-Qiong[1],Chou Ji-Yao[2],Li Ting[3],et al. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I[J]. Experimental dermatology,2018,27:201-204.
APA	Fu Xiu-Qiong[1].,Chou Ji-Yao[2].,Li Ting[3].,Zhu Pei-Li[4].,Li Jun-Kui[5].,...&Yu Zhi-Ling[12].(2018).The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I.Experimental dermatology,27,201-204.
MLA	Fu Xiu-Qiong[1],et al."The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I".Experimental dermatology 27(2018):201-204.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。